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ier Taiwan LLC. Open access under CSummary Background: Pyogenic granuloma (PG) is a polypoid form of capillary hemangioma.
This study aimed to analyze the clinical and endoscopic features of gastric PG.
Methods: We retrospectively reviewed nine patients with gastric PGs who were evaluated by
esophagogastroduodenoscopy and diagnosed by pathological study at the Chang Gung Medical
Center (Taoyuan, Taiwan) between 2000 and 2009. Demographic data, clinical presentations,
endoscopic findings, treatment, and outcome were collected and analyzed.
Results: The median age of the study patients was 62 years (range, 40e73 years) with a female
preponderance. The most common symptom at presentation was overt gastrointestinal
bleeding, followed by anemia and epigastralgia. Two patients were asymptomatic at diagnosis.
The most common underlying diseases were liver cirrhosis [5 (56%) patients] and hypertension
[5 (56%) patients]. Five (56%) cases of gastric PGs originated at the site of prior ulcer lesions.
Most gastric PGs were solitary [7 (78%) patients] and located in the antrum [8 (89%) patients].
The gastric PGs typically appeared morphologically as smooth protruding hyperemic lesions
with adherent white or yellow deposits. One patient received an endoscopic mucosal resection
with complete excision of the lesion. Another patient received surgical intervention. Four
gastric PG lesions were stationary or regressed with conservative management.
Conclusion: Overt gastrointestinal bleeding was the most common clinical presentation in pa-
tients with gastric PG. Gastric ulcers were the most common precursors of PG with the antrum
being the most frequent site involved. Gastric PGs were characteristically protruding hyper-
emic lesions with adherent exudates. Conservative treatment may be considered forof Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital and College of Medicine,
-Xing Street, Guishan Township, Taoyuan County 333, Taiwan.
.org.tw (C.-T.Chiu).
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Features of gastric pyogenic granuloma 119Figure 1 (A) Edematous collagen
granulation tissue. The infiltrate is
flammatory mononucleated cells are
by a single layer of flattened or rouasymptomatic PG patients with major comorbidities. Endoscopic resection may be offered to
patients with symptoms.
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ciety of Taiwan. Published by Elsevier Taiwan LLC.Open access under CC BY-NC-ND license.Introduction
Pyogenic granuloma (PG) is an inflammatory vascular lesion
that is generally a red polypoid mass of apparent granula-
tion tissue that bleeds easily [1]. The name PG is misleading
because it is not infectious, it does not form pus, and it is
not granulomatous. It is actually a polypoid form of capil-
lary hemangioma [2], which explains its tendency to bleed.
The most commonly affected sites are the extremities and
the oral cavity. Pyogenic granuloma is extremely rare in the
alimentary tract, except in the oral cavity [3]. To date, only
five case reports of gastric PG have been published [3e7].
The aim of the study is to evaluate the clinical pre-
sentations, endoscopic findings, treatment, and outcomes
of gastric PG in our case series.Methods
A retrospective chart review study was conducted that
targeted patients diagnosed with gastric PG at the Chang
Gung Medical Center (Taoyuan, Taiwan). We identified nine
patients who were diagnosed as having gastric PG between
January 2000 and September 2009.
Pyogenic granuloma was diagnosed based on the histo-
logical identification of a lobular arrangement of multiple
capillaries lined by endothelial cells, and edematous
stroma with inflammatory cell infiltration and fibroblast
proliferation in routine hematoxylin and eosin (HE)-stained
sections of formalin-fixed, paraffin-embedded materials
(Fig. 1) [4,7e9]. The specimens in all patients were ac-
quired by biopsy forceps from areas of polypoid lesions or
ulcers.ous stroma (s) with mixed infla
typically predominantly neutro
scattered in the deeper zones
nd endothelial cells (arrows) (hThe clinical parameters were collected from the medical
records and included age, sex, initial presentation, under-
lying disease, medications, prior lesions at the same site,
Helicobacter pylori (HP) infection, treatment, and
outcome. The endoscopic characteristics of gastric PG were
collected such as the indications for endoscopy, and the
location, size, number and gross appearance of lesions. Six
of the nine patients underwent follow-up esophagogas-
troduodenoscopy (EGD). Data on the follow-up duration,
the findings, and changes in the lesion size were recorded.Results
The median age of the study patients was 62 years (range,
40e73 years). Six patients were women and three patients
were men. The initial presentations included gastrointes-
tinal (GI) bleeding in four patients; anemia in two patients;
and epigastralgia in one patients. Two patients had no
symptoms at diagnosis. Among the nine patients, five
(55.56%) patients had liver cirrhosis, which included two
patients with hepatitis B virus infection, two patients with
hepatitis C virus infection, and one patient with primary
biliary cirrhosis. Five (55.56%) patients had hypertension,
three (33.33%) patients had diabetes mellitus, and two
(22.22%) patients had hepatocellular carcinoma. With re-
gard to the medication history, seven (77.78%) patients
had used proton pump inhibitors (PPIs) prior to the diag-
nosis of PG and four (44.44%) patients had used nonste-
roidal anti-inflammatory drugs (NSAIDs). Prior lesions at
the PG site were gastric ulcer (GU) in five (55.56%) patients
and subepithelial lesion in two patients. Endoscopic ul-
trasonography was performed on one subepithelial lesion,mmatory cell infiltration and fibroblast proliferation form the
philic near the ulcerated surface of the lesion and chronic in-
. (B) The lobular arrangement of capillaries (c), which are lined
ematoxylin and eosin stain; magnification, medium power).
Table 1 Clinical features of gastric pyogenic granuloma.
Case Age,
sex
Initial presentation Underlying disease Medication history Prior lesion
(time prior to PG Dx)
HP infection Treatment Outcome
1 40 y
F
GI bleeding HTN
Hypothyroidism
PPI
NSAID
GU (3 mo) P Gastrectomy Fatality
2 62 y
F
GI bleeding Liver cirrhosis, HCV
End-stage renal disease
Coronary artery disease
PPI SEL (40 mo) N Lost to f/u d
3 55 y
M
GI bleeding Liver cirrhosis, alcohol þ HBV
HTN
DM
HCC
PPI GU (6 mo) P EGD f/u (30 mo) Stationary
4 59 y
F
Asymptomatic Liver cirrhosis, PBC
DM
PPI GU (5 mo) P EGD f/u (4 mo) Regressive
5 69 y
F
GI bleeding Liver cirrhosis, HCV
HCC
PPI GU (2 mo) P Lost f/u d
6 68 y
M
Asymptomatic Liver cirrhosis, HBV
HTN
HCC
PPI
NSAID
GU (2.5 mo) P EGD f/u (10 mo) Regressive
7 73 y
F
Epigastralgia HTN
Rectal cancer status post operation
PPI
NSAID
SEL (1 mo) N EGD f/u (4 mo) Regressive
8 62 y
F
Anemia HTN
Autoimmune thyroid disease
NSAID Unknown N Endoscopic resection Cure
9 69 y
M
Anemia DM
Large B cell lymphoma (bone marrow)
d Unknown N Lost to f/u d
DM Z diabetes mellitus; Dx Z diagnosis; EGD Z esophagogastroduodenoscopy; F Z female; f/u Z follow-up; GI Z gastrointestinal; GU Z gastric ulcer; HBV Z hepatitis B virus;
HCC Z hepatocellular carcinoma; HCV Z hepatitis C virus; HP Z Helicobacter pylori; HTN Z hypertension; M Z male; mo Z month; N Z negative; NSAID Z nonsteroidal anti-
inflammatory drug; P Z positive; PBC Z primary biliary cirrhosis; PG Z pyogenic granuloma; PPI Z proton pump inhibitor; SEL Z subepithelial lesion; y Z years.
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Features of gastric pyogenic granuloma 121which presented as a well-defined inhomogeneous hypo-
echoic tumor arising from the second layer of the mucosa.
Endoscopic ultrasonography was not performed on one
lesion because of the patient’s unstable clinical condition.
Two patients had not undergone EGD prior to the diagnosis
of gastric PG. The median duration between the GU and
the diagnosis of PG was 3 months. At the time of the
diagnosis of PG, five patients had an HP infection, which
was confirmed by pathological examination (Tables 1
and 2).
The indications for endoscopy were bleeding survey in
four patients, follow up for GU in two patients, anemia in
two patients, and abdominal pain in one patient. The PGs
were located in the antral area of the stomach in eight
patients and in the body of the stomach in one patient. The
median size of lesions was 2.5 cm (range, 0.9e3 cm). They
were solitary lesions in seven patients, two lesions in one
patient, and multiple (i.e., >3) lesions in one patient. All
lesions were of the protruding type with pedunculated le-
sions in two patients and semipedunculated lesions or
sessile lesions in seven patients. The lesions appeared hy-
peremic in six patients and pink in three patients. The
surface of the lesions was smooth in five patients, erosive
in two patients, and ulcerated in two patients. SevenTable 2 Characteristics of the gastric pyogenic
granulomas.
Age (y) 40e73
(median, 62)
Sex (male/female) 3/6
Initial presentation
Gastrointestinal bleeding 4 (44.44)
Epigastralgia 3 (33.33)
Anemia 2 (22.22)
No symptoms 2 (22.22)
Underlying disease
Liver cirrhosis 5 (55.56)
Etiology of liver cirrhosis (HBV/HCV/PBC) 2/2/1
Hypertension 5 (55.56)
Diabetes mellitus 3 (33.33)
Hepatocellular carcinoma 2 (22.22)
End-stage renal disease 1 (11.11)
Hypothyroidism 1 (11.11)
Coronary artery disease 1 (11.11)
Autoimmune thyroid disease 1 (11.11)
Bone marrow large B cell lymphoma 1 (11.11)
Rectal cancer status post operation 1 (11.11)
Medication history
Proton pump inhibitor 7 (77.78)
Nonsteroidal anti-inflammatory drug 4 (44.44)
Prior lesion on the same site
Gastric ulcer 5(55.56)
Median time to the diagnosis of PG 3 mo (2e6 mo)
Subepithelial lesion 2 (22.22)
Helicobacter pylori infection at time of
the diagnosis
5 (55.56)
With the exception of age and sex, the data are presented as n
(%).
HBV Z hepatitis B virus; HCV Z hepatitis C virus;
PBC Z primary biliary cirrhosis.patients had adherent white or yellow deposits on the
lesions (Table 3).
Six patients had follow-up EGD after diagnosis. The
median follow-up duration was 4 months (range, 2e26
months). One patient who had underlying hypertension and
hypothyroidism underwent gastrectomy because of intrac-
table epigastric pain and GI bleeding. However, she even-
tually died because of septic shock after surgery. One
patient received endoscopic resection of the lesion without
recurrence. The other four patients took a histamine 2 re-
ceptor antagonist or proton pump inhibitor for >3 months
after the index endoscopy. One lesion was stationary in size
and three lesions regressed (Figs. 2 and 3).Discussion
In 1897, the cutaneous form of PG (i.e., “human botryo-
mycosis”) was initially described by two French surgeons,
[30]. However, in 1904, Hartzell coined the term “pyogenic
granuloma” [3]. In 1967, Payson et al. [31] and associates
published the first well-documented case report of the GI
tract PG [4]. To our knowledge, approximately 65 cases of
PG in the alimentary tract (other than in the oral mucosa)
have been published in the literature. The reports have
described 19 cases of PG in the esophagus [10e14]; five
cases in the stomach; 20 cases in the small intestine
[10,11,14e18]; 19 cases in the colon [10,19e25]; one case
in an unidentified area of the alimentary tract [26]; and one
case in the common bile duct [1]. The patients’ ages ranged
from 1.5 years to 82 years (mean age, 49.97 years) and
56.36% of the patients were male. In our case series and
in five other previously published reports on gastric PG
(Table 4), the lesions occurred in middle-aged people and
more frequently in female patients than in male patients
with a female:male ratio of approximately 8:6.
The clinical presentation of the GI tract PG depends
on its site [4]. Gastrointestinal bleeding is the most
common presenting symptom (in 34.55% of cases)
[3,11,18,19,21,23,24,26]. Overt GI bleeding was the most
common clinical presentation in our series, and gastric PG
should be considered a source of hemorrhage in patients
presenting with overt GI bleeding or iron deficiency
anemia.
Liver cirrhosis was one of the most common underlying
diseases in the present study. To date, no analysis of the
underlying disease in patients with gastric PG has been re-
ported. Only two patients with PG in the small boweldboth
of whom had liver cirrhosisdwere mentioned previously,
but the association or possible mechanisms that increase PG
in cirrhotic patients remained unclear [18]. Two hypotheses
have been suggested, based on the previous study: portal
hypertension and hormone imbalance. Portal hypertension
may form venous stasis with retrograde dilatation of the
venous and capillary blood vessels and cause growth of
preexistent vascular lesions (i.e., produce a hemangioma)
in the GI tract [27,28]. Hormone imbalance may also be
suspected as a cause of PG, as in the case of spider angi-
omas. Increased plasma levels of vascular endothelial
growth factor and basic fibroblast growth factor are the
most significant predictors of the presence of spider angi-
omas in cirrhotic patients [28].
Table 3 Endoscopic features of gastric pyogenic granuloma.
Case Indication Site Size (cm) No. of lesions Gross appearance Follow-up
duration
Finding Change in
size (cm)Morphology Color Surface Adherent white
or yellow deposits
1 Bleeding survey Antrum 3 Single Semipedunculated
Lobulated
Pink Smooth P 2 mo Stationary 3/ 3
2 Bleeding survey Antrum 3 Single Semipedunculated
Lobulated
Hyperemic Ulcerated P Lost f/u
3 Bleeding survey Antrum 2.5 Single Semipedunculated
Polypoid
Pink Smooth N 26 mo Stationary 2.5/ 2.5
4 GU f/u Antrum 0.9 and 3 Two Sessile
Polypoid
Hyperemic Erosive P 5 mo. Regressive 0.9/ 0.3
3/ 0.5
5 Bleeding
survey
Antrum 2.5 Single Sessile
Lobulated
Hyperemic Smooth P Lost to f/u
6 GU f/u Antrum 2 Single Sessile
Lobulated
Hyperemic Erosive P 10 mo Regressive 2/ 0.3
7 Abdominal pain survey Antrum 2.5 Single Sessile
Polypoid
Pink Ulcerated N 4 mo Regressive 2.5/ 1
8 Anemia survey Body 1e3 Multiple Pedunculated
Polypoid
Hyperemic Smooth P 4 mo Cure 1e3/ 0
9 Anemia survey Antrum 2.5 Single Pedunculated
Polypoid
Hyperemic Ulcerated P Lost to f/u
f/u Z follow-up; GU Z gastric ulcer; N Z negative; P Z positive.
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Figure 2 Case 4. A 59-year-old woman had GI bleeding. The EGD showed gastric ulcers in October 2008. At a regular follow-up
EGD, PGs were diagnosed by pathological study in April 2009. Sequential endoscopic findings between October 2008 and August
2009 are shown. (A) One 2-cm active ulcer is present on the anterior wall of the antrum in October 2008. (B) Three months later, the
ulcer has healed and a mild mucosal elevation with an irregularly polypoid surface is at the same site. (C) Five months later, the PG
is at the same site of the prior ulcer. (D) The PG subsequently regressed 5 months later. EGD Z esophagogastroduodenoscopy;
GI Z gastrointestinal; PG Z pyogenic granuloma.
Figure 3 Case 6. A 68-year-old man underwent regular follow-up EGDs for GU since January 2005. In June 2009, he was diagnosed
by pathology as having PG. Sequential endoscopic findings between January 2005 and March 2010 are shown. (A) In January 2005,
one tiny erosion was present on the posterior wall of the antrum. (B) In March 2009, two 1-cm active ulcers were present in the
posterior wall of the antrum. (C) Three months later, one 2-cm hyperemic sessile lesion appeared at the same site of the prior ulcer.
Endoscopic biopsy proved it was PG. (D) Nine months later, the PG had finally regressed. EGD Z esophagogastroduodenoscopy;
GU Z gastric ulcer; PG Z pyogenic granuloma.
Features of gastric pyogenic granuloma 123In 55.56% of the patients in our case series, GU was
previously identified at the same site of gastric PG prior to
the index endoscopic examination. Previous studies suggest
that GI tract PGs may emerge at sites of previous inflam-
mation of ulceration [4]. Our findings support the hypoth-
esis that PG may be reactive and induced by trauma with a
subsequent overgrowth of granulation tissue.
Gastric PGs are mostly semipedunculated or sessile; less
frequently they are pedunculated. This finding is slightly
different from lesions at other sites of the GI tract where
lesions are typically pedunculated or semipedunculated
and, less frequently, sessile [4]. Adherent white or yellow
deposits on the surface of the lesion is a characteristic
feature of PG. Serban and Florescu [29] analyzed cases of
PG in the colons of children. They believe that the endo-
scopic detection of an adherent white or yellow deposit on
the mucosa or on polypoid lesions is suggestive of PG, and
the endoscopic sensitivity and specificity are both 100%
[29].
Complete excision is reportedly the optimal manage-
ment for GI tract PG [4,29]. Endoscopic resection is the
most favorable treatment for GI tract PG and has beenreported in 63.33% of patients [3e7,10,12e19,21,23,24].
Only one patient developed perforation at the site of pol-
ypectomy and then underwent surgical repair; however, he
recovered and was discharged 5 days later [23]. The second
choice for the treatment of GI tract PG was surgical
resection. Furthermore, successful combination therapy
with embolization of the nutritional artery for the lesion
and endoscopic resection has been reported for a large
gastric PG [3]. In our series, four gastric PG lesions were
stationary or regressed with conservative management.
Therefore, conservative treatment may be an option in
asymptomatic PG patients with major comorbidities.
In conclusion, overt GI bleeding was the most common
clinical presentation, and liver cirrhosis was a common
underlying disease in patients with gastric PG in our series.
Gastric ulcer was the most common precursor of PG with
the antrum being the most frequent site involved. Gastric
PGs were characteristically protruding hyperemic lesions
with adherent exudates. Endoscopic resection may be
offered to patients with symptoms. Conservative treatment
may be considered for asymptomatic patients with PG with
major comorbidities.
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